Contact Information

Biography

Devika S Manickam, Ph.D., is a bioengineer and an Associate Professor in the Division of Pharmaceutical Sciences at Duquesne University School of Pharmacy. She completed her Bachelors in Chemical Engineering at University of Madras in India and received her Masters and PhD in Pharmaceutical Sciences from Wayne State University in Detroit, MI under the mentorship of Prof. David Oupický.

Dr. Manickam completed her postdoctoral training at the University of Nebraska Medical Center under the mentorship of Prof. Alexander (Sasha) Kabanov. She also worked as a Research Assistant Professor at the University of North Carolina at Chapel Hill prior to moving to Duquesne.

Dr. Manickam's scholarship has resulted in over 40 peer-reviewed publications and book chapters. 

Education

  • Post-Doctoral Training, University of Nebraska Medical Center, 2010
  • Ph.D., Pharmaceutical Sciences, Wayne State University, 2008
  • M.Sc., Pharmaceutical Sciences, Wayne State University, 2005
  • B.Tech., Chemical Engineering, University of Madras, 2003

Research Interests

  • Drug delivery to the blood-brain barrier (BBB) and to cellular targets beyond the BBB

  • Mitochondria delivery using extracellular vesicles (EVs)

  • Engineered extracellular vesicles for co-delivery of innate EV mitochondria and exogenous biologic drugs (proteins/nucleic acids)

  • Re-engineering of lipid nanoparticles using ionic liquids

    For research opportunities and more information, please refer to Dr. Manickam's laboratory website at https://manickamlab.wordpress.com/.

 

 

 

School

Please refer to Dr. Manickam's laboratory website at https://manickamlab.wordpress.com/.

Intellectual Property:

  • A. V. Kabanov, D. S. Manickam. "Composition and Methods for Lung Inflammation Therapies", International Publication Number: US 2013/0052154 A1 published 02/28/2013.
  • A. V. Kabanov, D. S. Manickam, A. M. Brynskikh. "Nanozyme Composition and Method of Synthesis and Use Thereof", International Publication Number: WO2012/162490 published 11/29/2012.
  • A. V. Kabanov, N. L. Klyachko, O.A. Kost, I. I. Nikolskaya, P. V. Binevski, D. S. Manickam. "Pharmaceutical composition for the topical treatment of inflammatory eye diseases and its use thereof", Russian patent application No. 2012130852 filed on 7/19/2012.

Original Research Articles:

  • N. M. Harris, R. Ritzel, N. Mancini, Y. Jiang, X. Yi, D.S. Manickam, W.A. Banks, A.V. Kabanov, L.D. McCullough and R. Verma. "Nano-particle Delivery of Brain Derived Neurotrophic Factor after Focal Cerebral Ischemia reduces Tissue Injury and Enhances Behavioral Recovery." Pharmacology, Biochemistry and Behavior, 2016, 2016, 150-151, 48-56.
  • Y. Jiang, P. Arounleut, S. Rheiner, Y. Bae, A.V. Kabanov, C. Milligan and D.S. Manickam†. "SOD1 Nanozyme with Reduced Toxicity and MPS Accumulation." Journal of Controlled Release, 2016, 231, 38-49 (†senior corresponding author).
  • V. Saraswathi, M. Ganesan; C. Perriotte-Olson, D.S. Manickam; R. A Westwood, M.C. Zimmerman, I. M Ahmad, C. V. Desouza, A. V Kabanov. "Nanoformulated Copper/Zinc Superoxide Dismutase Attenuates Vascular Cell Activation and Aortic Inflammation in Obesity." Biochemical and Biophysical Research Communications, 2016, 469(3), 495-500.
  • C. Perriotte-Olson, N. Adi, D.S. Manickam, R. A. Westwood, C. V. Desouza, A. V. Kabanov, and S. Viswanathan. "Nanoformulated Copper/Zinc Superoxide Dismutase Reduces Adiposity and Adipose Inflammation in Obesity." Obesity, 2016, 24(1), 148-56.
  • O.A. Kost, O.V. Beznos, N.G. Davydova, D.S. Manickam, I.I. Nikolskaya, A.E. Guller, P.V. Binevski, N.B. Chesnokova, A.B. Shekhter, N.L. Klyachko, A.V. Kabanov "." Oxidative Medicine and Cellular Longevity, 2016, vol. 2016, Article ID 5194239.
  • Y. Jiang, A.M. Brynskikh, D.S. Manickam† and A.V. Kabanov†. "SOD1 Nanozyme Salvages Ischemic Brain by Locally Protecting Cerebral Vasculature." Journal of Controlled Release, 2015, 213, 36-44 (†senior co-corresponding author).
  • Z. He, L. Miao, R. Jordan, D.S. Manickam, R. Luxenhofer, A.V. Kabanov. "A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector." Macromolecular Bioscience, 2015, 15, 1004-1020.
  • K.K. Savalia, D.S. Manickam, E.G. Rosenbaugh, J. Tian, I.M. Ahmad, A.V. Kabanov, M.C. Zimmerman. Neuronal Uptake of Nanoformulated Superoxide Dismutase and Inhibition of Angiotensin II-Dependent Hypertension Following Central Administration. Free Radical Biology and Medicine, 2014, 73, 299-307.
  • N.L. Klyachko, M.H. Haney, Y. Zhao, D.S. Manickam, V. Mahajan, P. Suresh, R.L. Mosley, H.E. Gendelman, A.V. Kabanov, E.V. Batrakova. "Macrophages Offer a Paradigm Switch for CNS Nanozyme Delivery." Nanomedicine, 2013, 1-18.
  • D.S. Manickam†, A.M. Brynskikh, J.L. Kopanic, P.L. Sorgen, N.L. Klyachko, E.V. Batrakova,
    T.K. Bronich and A.V. Kabanov†. "Well-defined Antioxidant Nanozymes for Treatment of Ischemic Brain Injury." Journal of Controlled Release, 2012, 162(3), 636-45. (†corresponding senior author).
  • J. Li, D.S. Manickam, J. Chen, D. Oupický. "Effect of Reduction-triggered Disassembly on Transfection Activity of Bioreducible Polyplexes." European Journal of Pharmaceutical Sciences, 2012, 46(3), 173-80.
  • N.L. Klyachko*, D.S. Manickam*, A.M. Brynskikh, S. Li, S.M. Higginbotham, T.K. Bronich, E.V. Batrakova, A.V. Kabanov. "Cross-Linked Antioxidant Nanozymes for Improved Delivery to CNS." (*equal contribution), Nanomedicine: Nanotechnology, Biology and Medicine, 2012, 8(1), 119-29.
  • E.G. Rosenbaugh, J. Roat, L. Gao, R-F. Yang, D.S. Manickam, J-X. Yin, H.D. Schultz, T.K. Bronich, E.V. Batrakova, A.V. Kabanov, I.H. Zucker, M.C. Zimmerman. "Nanoformulated Copper/Zinc Superoxide Dismutase Attenuates Central Angiotensin II-dependent Pressor Response and Intra-neuronal Signaling." Biomaterials, 2010, 31(19), 5218-5226.
  • D.S. Manickam, J. Li, D. A. Putt, Q.H. Zhou, C. Wu, L.H. Lash and D. Oupický. "Effect of Innate Glutathione Levels on Activity of Redox-responsive Gene Delivery Vectors." Journal of Controlled Release, 2010, 141, 77-84.
  • Q.H. Zhou, C. Wu, D.S. Manickam and D. Oupický. "Evaluation of Pharmacokinetics of Bioreducible Gene Delivery Vectors by Real-time PCR." Pharmaceutical Research, 2009, 26(7), 1581-1589.
  • S. Kakade, D.S. Manickam, H. Handa, G. Mao, and D. Oupický. "Transfection Activity of Layer- by-Layer Plasmid DNA/Poly(ethylenimine) Films Deposited on PLGA Microparticles." International Journal of Pharmaceutics, 2009, 365(1-2), 44-52.
  • L. Wan, D.S. Manickam, D. Oupický, and G. Mao. "DNA Release Dynamics from Reducible Polyplexes by Atomic Force Microscopy." Langmuir, 2008, 24(21), 12474-12482.
  • D.S. Manickam, A. Hirata, D.A. Putt, L.H. Lash, F. Hirata and D. Oupický. "Overexpression of Bcl-2 as a Proxy Redox Stimulus to Enhance Activity of Reducible Gene Delivery Vectors." Biomaterials, 2008, 29, 2680-2688.
  • U.L. Rahbek, K.A. Howard, D. Oupický, D.S. Manickam, M. Dong, A.F. Nielsen, F. Besenbacher and J. Kjems. "Intracellular siRNA and Precursor miRNA Trafficking Using Bioresponsive Copolypeptides." Journal of Gene Medicine, 2008, 10(1), 81-93.
  • Y.Z. You, Q.H. Zhou, D.S. Manickam, L. Wan, G.Z. Mao, and D. Oupický. "Dually Responsive Multiblock Copolymers via RAFT Polymerization: Synthesis of Temperature- and Redox- responsive Copolymers of PNIPAM and PDMAEMA." Macromolecules, 2007, 40(24), 8617-8624.
  • Y-Z. You, D.S. Manickam, Q.H. Zhou and D. Oupický. "A Versatile Approach to Reducible Vinyl Polymers via Oxidation of Telechelic Polymers Prepared by Reversible Addition Fragmentation Chain Transfer Polymerization." Biomacromolecules, 2007, 8, 2038-2044.
  • Y-Z. You*, D.S. Manickam*, Q.H. Zhou and D. Oupický. "Reducible Poly(2- dimethylaminoethylmethacrylate): Synthesis, Cytotoxicity, and Gene Delivery Activity." Journal of Controlled Release, 2007, 122, 217-225. (*equal contribution)
  • J. Blacklock, H. Handa, D.S. Manickam, G. Mao, A. Mukhopadhyay and D. Oupický. "Disassembly of Layer-by-Layer Films of Plasmid DNA and Reducible TAT Polypeptide." Biomaterials, 2007, 28, 117-124.
  • D.S. Manickam and D. Oupický. "Multiblock Reducible Copolypeptides Containing Histidine- rich and Nuclear Localization Sequences for Gene Delivery." Bioconjugate Chemistry, 2006, 17, 1395-1403.
  • H.S. Bisht*, D.S. Manickam*, Y. You, and D. Oupický. "Temperature-Controlled Properties of DNA Complexes with Poly (ethylenimine)-graft-poly (N-isopropylacrylamide)." Biomacromolecules, 2006, 7, 1169-1178. (*equal contribution).
  • D.S. Manickam, H. S. Bisht, L. Wan, G. Mao and D. Oupický. "Influence of TAT-peptide Polymerization on Properties and Transfection Activity of TAT/DNA Polyplexes." Journal of Controlled Release, 2005, 102(1), 293-306.

Book Chapters:

  • Y. Zhu, J. Li, Y. Wang, D.S. Manickam, Y. You, D. Oupický. "Redox-responsive polymer-based gene delivery systems." In Gene and Cell Therapy: Therapeutic Mechanisms and Strategies. 4th Edition, Ed. N. S. Templeton, Taylor and Francis, Boca Raton, 2014.
  • D. Oupický, Y. You and D.S. Manickam. "Redox-responsive Polymer-based Gene Delivery Systems." In Gene and Cell Therapy: Therapeutic Mechanisms and Strategies. 3rd Edition, Ed. N. S. Templeton, Taylor and Francis, Boca Raton, 2007.

Conference Contributions/Abstracts:

  • Y. Jiang, P. Arounleut, S. Rheiner, Y. Bae, A. V. Kabanov, C. Milligan, D.S. Manickam†. "Nano-antioxidant Therapy for Amyotrophic Lateral Sclerosis." 2014 Gordon Research Conference on Drug Carriers in Medicine and Biology. Waterville Valley, NH. August 2014. (†senior corresponding author).
  • Y. Jiang, P. Arounleut, S. Rheiner, Y. Bae, A. V. Kabanov, C. Milligan, D.S. Manickam†. "Nano-antioxidant Therapy for Amyotrophic Lateral Sclerosis." 2014 Gordon Research Seminar and Conference on Barriers to the CNS. New London, NH. June 2014. (†senior corresponding author).
  • Y. Jiang, A. M. Brynskikh, D.S. Manickam, M. Boska, T.K. Bronich, A.V. Kabanov. "SOD1 Nanozyme Salvages Ischemic Brain by Protecting Cerebral Vasculature." 2014 Gordon Research Seminar and Conference on Barriers to the CNS. New London, NH. June 2014.
  • (4) Y. Jiang, K. Bullock, D.S. Manickam, C-D Poon, W. A. Banks, X. Yi, A. V. Kabanov. "Brain Delivery of Nano-BDNF: A Potential Therapy for BDNF Associated Neurological Disorders." 2014 Gordon Research Seminar and Conference on Barriers to the CNS. New London, NH. June 2014.
  • K. K. Savalia, D.S. Manickam, E. G. Rosenbaugh, J. Tian, I. M. Ahmad, A.V. Kabanov, M. C. Zimmerman. "Nanoformulated Copper/Zinc Superoxide Dismutase: Alternative Therapeutic Strategy for Angiotensin II-dependent Neurogenic Hypertension." 2013 American Heart Association High Blood Pressure Council meeting, New Orleans, LA. November 2013.
  • Y. Jiang, A. B. Boyum, D.S. Manickam, M. Boska, T.K. Bronich, A.V. Kabanov. "SOD1 Nanozyme Co-localize with Post-stroke Thrombi after Reperfusion in a Rat MCAO Model." 11th Nanomedicine and Drug Delivery Symposium, La Jolla, CA. October 2013.
  • E. G. Rosenbaugh, D.S. Manickam, J. Tian, I. M. Ahmad, A. V. Kabanov, M. C. Zimmerman. "Nanoformulated Copper Zinc Superoxide Dismutase Inhibits the Central Angiotensin II-Mediated Pressor Response and Hypertension." FASEB Science Research Conference, Neural Mechanisms in Cardiovascular Regulation. Gleneden Beach, OR. July 2013.
  • M. C. Zimmerman, U. Basu, E. G. Rosenbaugh, K. K. Savalia, D.S. Manickam, A. V. Kabanov. "Oxidants, Antioxidants, and Hypertension: It's All in Your Head." FASEB Summer Conference on Renal Hemodynamics (Invited lecture presented by MCZ). Saxtons River, VT. July 2013.
  • L. Miao, Z. He, Y. Jiang, S. Rheiner, Y. Bae, R. Luxenhofer, D.S. Manickam†, A.V. Kabanov. "Polymeric Carriers for the Delivery of Neurotrophins to the Brain." 16th Annual Meeting of the American Society of Gene and Cell Therapy, Salt Lake City, UT, May 2013 (†senior corresponding author).
  • D.S. Manickam, A. M. Brynskikh, J. L. Kopanic, P. L. Sorgen, N. L. Klyachko, E. V. Batrakova, T. K. Bronich and A.V. Kabanov. "Well-defined Antioxidant Nanozymes for Treatment of Ischemic Brain Injury." Gordon Research Seminar (oral presentation) and Conference on Barriers to the CNS, New London, NH, June 2012.
  • AACP New Investigator Award, 2017
  • IBM Junior Faculty Development Award, 2014, UNC-CH
  • Licensed Technology Award, 2012 Innovation Awards Ceremony, UNMC and the UNeMed Corporation
  • New Invention Notification (Multiples) Award, 2011 Innovation Awards Ceremony, UNMC and the UNeMed Corporation
  • Travel award to attend the 8th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice, 2010
  • Travel award to attend the Annual Meeting of the American Society of Gene Therapy, 2007 and 2008
  • Outstanding Student Poster Award, 2007 Annual Research Forum, Eugene Applebaum College of Pharmacy and Health Sciences, WSU

Leadership Activities

  • Serves as a peer-reviewer for the following journals: Molecular Pharmaceutics, Journal of Controlled Release and Macromolecular Bioscience.
  • Co-director (2014-2015), Carolina Nanoformulation Workshop (https://pharmacy.unc.edu/cnw), jointly hosted by the CNDD and the Carolina Institute for Nanomedicine, UNC-CH.
  • Session Chair - Gene and siRNA Delivery, 12th International Nanomedicine and Drug Delivery Symposium, October 2014 (Chapel Hill, NC).
  • Poster Judge, 12th International Nanomedicine and Drug Delivery Symposium, October 2014 (Chapel Hill, NC).
  • Poster Award Committee, Annual Pharmaceutical Sciences Awards Ceremony and Research Day, UNC Eshelman School of Pharmacy, August 2014, UNC-CH.
  • Judged podia presentations in the 44th Annual Post Graduate Students Research Meeting, June 2012 (Omaha, NE).
  • Seminar coordinator (2010-2011), Nanomaterials Core Seminar Series (monthly), Center for Drug Delivery and Nanomedicine, UNMC (Omaha, NE).
  • Co-chaired the session on ‘Nanomedicines in Cancer' at the 8th International Nanomedicine and Drug Delivery Symposium, October 2010 (Omaha, NE).
  • Co-chaired the session on ‘Polymer Therapeutics: New Synthetic Approaches and Analytical Tools' at the 8th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice, May 2010 (Valencia, Spain).

Professional Activities

  • Interviewed candidates for the Ph.D. program in Molecular Pharmaceutics (incoming class of fall 2014), UNC Eshelman School of Pharmacy.
  • Scientific Consultant (4/2013–11/2015), Nanomedicine Characterization Core Facility, Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, UNC-CH.
  • Advisor and Co-inventor (2013– ), nanoZYME technology, NeuroNano Pharma Inc. (Chapel Hill, NC).
  • Member of the abstract review group for the 8th International Nanomedicine and Drug Delivery Symposium, October 2010 (Omaha, NE).

Peer Reviewer:

  • Journal of Controlled Release
  • Advanced Healthcare Materials
  • Pharmaceutical Research
  • Journal of Biomaterials Science: Polymer Edition
  • Expert Review of Nanomedicines
  • Therapeutic Delivery
  • Molecular Pharmaceutics
  • PLoS ONE